As recently reported in the publication Hospital Pharmacy Europe a Belgium virologist named Marc Wathelet argues for the immediate use of ivermectin as a low-cost, off-label treatment to get the pandemic under control in Belgium. After providing a brief history of the first attempts at repurposing at the pandemic onset, Dr. Wathelet suggests after one year, and billions spent by governments such as those from America, only one drug is actually proven to have benefits—dexamethasone from the RECOVERY trial for patients who were already hypoxemic.
